Physician profile
Michael Schechter
NPI 1164800140
$1,586.60
in general payments reported to CMS, 2019-2025
11 companies · $337 in 2025
The $337 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8.12 · 2021: $240 · 2022: $463 · 2023: $208 · 2024: $330 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $875.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,189.70 | 2021-2025 | Intellis Adaptivestim, Anteralign Spinal System With Titan Nanolock Surface Technology, Accurian |
| Sanofi-Aventis U.S. LLC | $130.20 | 2021-2023 | |
| Si-Bone, INC. | $64.94 | 2023-2024 | |
| Fidia Pharma USA INC. | $54.03 | 2022-2024 | Hymovis, Triluron, Hyalgan |
| Boston Scientific Corporation | $30.45 | 2022-2023 | |
| Saluda Medical Americas, INC. | $30.20 | 2025 | Evoke |
| Grt US Holding, INC. | $24.68 | 2022 | |
| Scilex Pharmaceuticals INC. | $21.61 | 2021 | |
| Biotronik Nro, INC. | $18.31 | 2025 | Prospera |
| Medline Industries LP | $14.36 | 2023 | |
| Cardiovascular Systems INC. | $8.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Schechter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.